{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T05:20:31Z","timestamp":1745126431104},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ihj.2018.05.010","type":"journal-article","created":{"date-parts":[[2018,5,26]],"date-time":"2018-05-26T12:18:12Z","timestamp":1527337092000},"page":"S64-S67","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S3","title":["Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in na\u00efve dyslipidemic patients"],"prefix":"10.1016","volume":"70","author":[{"given":"Manoj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmeet Singh","family":"Rehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhur","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2018.05.010_bib0005","series-title":"Non Communicable Disease [Internet]","author":"WHO","year":"2017"},{"key":"10.1016\/j.ihj.2018.05.010_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2018.05.010_bib0015","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","article-title":"Cardiovascular Diseases in India: Current Epidemiology and Future Directions","volume":"133","author":"Prabhakaran","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.05.010_bib0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4330\/wjc.v8.i3.247","article-title":"Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: current state and future directions","volume":"8","author":"Bilen","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/j.ihj.2018.05.010_bib0025","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and Coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2018.05.010_bib0030","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2125.2003.02060.x","article-title":"Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes","volume":"57","author":"Cheung","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ihj.2018.05.010_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.ihj.2018.05.010_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOL.0b013e32825a6773","article-title":"The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis","volume":"18","author":"Harper","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ihj.2018.05.010_bib0045","first-page":"605","article-title":"Review: statins and liver injury","volume":"9","author":"Thapar","year":"2013","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"10.1016\/j.ihj.2018.05.010_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/aoms.2015.49807","article-title":"Statin intolerance \u2013 an attempt at a unified definition: position paper from an International Lipid Expert Panel","volume":"11","author":"Banach","year":"2015","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ihj.2018.05.010_bib0055","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0002-8703(02)00140-0","article-title":"Is alternative daily dose of atorvastatin effective in treating patients with hyperlipidemia? The alternate day versus daily dosing of atorvastatin study (ADDAS)","volume":"144","author":"Matalka","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ihj.2018.05.010_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/107424840300800205","article-title":"Efficacy of alternate-day dosing versus daily dosing of atorvastatin","volume":"8","author":"Jafari","year":"2003","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ihj.2018.05.010_bib0065","first-page":"163","article-title":"Efficacy of alternate day dosing of atorvastatin","volume":"3","author":"Aghasadeghi","year":"2007","journal-title":"Cent Eur J Med"},{"key":"10.1016\/j.ihj.2018.05.010_bib0070","first-page":"407","article-title":"The comparison of the effects of standard 20\u202fmg atorvastatin daily and 20\u202fmg of atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels","volume":"8","author":"Keles","year":"2008","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.ihj.2018.05.010_bib0075","first-page":"90","article-title":"Alternate versus daily atorvastatin in CAD","volume":"12","author":"Rifaie","year":"2012","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.ihj.2018.05.010_bib0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.ihj.2018.05.010_bib0085","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Expert panel on detection. evaluation and treatment of high blood cholesterol in adults (Adult panel treatment III) final report","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2018.05.010_bib0090","series-title":"ADR Reporting [Internet]","author":"Pharmacovigilance Program of India","year":"2018"},{"key":"10.1016\/j.ihj.2018.05.010_bib0095","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ihj.2018.05.010_bib0100","first-page":"7","article-title":"Lipid association of India expert consensus statement on management of dyslipidemia in indians 2016: part 1","volume":"64","author":"Iyengar","year":"2016","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.ihj.2018.05.010_bib0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ihj.2016.07.007","article-title":"Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients","volume":"69","author":"Grover","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2018.05.010_bib0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"Final conclusions and recommendations of the national lipid association statin safety assessment task force","volume":"97","author":"McKenney","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ihj.2018.05.010_bib0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4065\/mcp.2009.0365","article-title":"Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma","volume":"85","author":"Calderon","year":"2010","journal-title":"Mayo Clin Proc"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217309331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217309331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T01:28:27Z","timestamp":1547256507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483217309331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":23,"alternative-id":["S0019483217309331"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2018.05.010","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in na\u00efve dyslipidemic patients","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2018.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}